BRETT EKSTROM: Open Payments
NPI 1104335900 · HUDSON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$402 in 19 payments from 12 companies in 2025. Trend: 2023 $257 · 2024 $363 · 2025 $402
Food & beverage: $402
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $83 |
| PFIZER INC. | 2 | $43 |
| Novartis Pharmaceuticals Corporation | 2 | $38 |
| Amgen Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $37 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| HEARTFLOW, INC. | 1 | $22 |
| Vital Connect, Inc | 1 | $21 |
Products named: CAMZYOS, ELIQUIS, LEQVIO, Repatha, Kerendia, NURTEC ODT, AIRSUPRA, ONPATTRO.
Industry payments across MA — which companies pay providers there.
